Increased resistance to CD4⁺CD25^hi regulatory T cell-mediated suppression in patients with type 1 diabetes

Authors: Lawson, J. M.¹; Tremble, J.²; Dayan, C.³; Beyan, H.⁴; Leslie, R. D. G.⁴; Peakman, M.; Tree, T. I. M.¹

Source: Clinical & Experimental Immunology, Volume 154, Number 3, December 2008 , pp. 353-359(7)

Buy & download fulltext article:

You have access to the full text article on a website external to ingentaconnect.

Please click here to view this article on Wiley Online Library.

You may be required to register and activate access on Wiley Online Library before you can obtain the full text. If you have any queries please visit Wiley Online Library

Abstract:

Summary

Type I diabetes (T1D) is a T cell-mediated autoimmune disease characterized by loss of tolerance to islet autoantigens, leading to the destruction of insulin-producing beta cells. Peripheral tolerance to self is maintained in health through several regulatory mechanisms, including a population of CD4⁺CD25^hi naturally occurring regulatory T cells (T_regs), defects in which could contribute to loss of self-tolerance in patients with T1D. We have reported previously that near to T1D onset, patients demonstrate a reduced level of suppression by CD4⁺CD25^hi T_regs of autologous CD4⁺CD25^- responder cells. Here we demonstrate that this defective regulation is also present in subjects with long-standing T1D (> 3 years duration; P = 0·009). No difference was observed in forkhead box P3 or CD127 expression on CD4⁺CD25^hi T cells in patients with T1D that could account for this loss of suppression. Cross-over co-culture assays demonstrate a relative resistance to CD4⁺CD25^hi T_reg-mediated suppression within the CD4⁺CD25^- T cells in all patients tested (P = 0·002), while there appears to be heterogeneity in the functional ability of CD4⁺CD25^hi T_regs from patients. In conclusion, this work demonstrates that defective regulation is a feature of T1D regardless of disease duration and that an impaired ability of responder T cells to be suppressed contributes to this defect.

Keywords: autoimmunity; diabetes; immune regulation; regulatory T cells

Document Type: Research article

DOI: http://dx.doi.org/10.1111/j.1365-2249.2008.03810.x

Affiliations: 1: King's College London, Department of Immunobiology and 2: Queen Elizabeth Hospital NHS Trust, London, 3: University Department of Medicine, Bristol Royal Infirmary, and 4: Institute of Cell and Molecular Science, Centre for Diabetes and Metabolic Medicine, Bart's and The London, UK

Publication date: 2008-12-01